What proportion of initially prescribed antidepressants is still being prescribed chronically after 5 years in general practice? A longitudinal cohort analysis - PubMed (original) (raw)
What proportion of initially prescribed antidepressants is still being prescribed chronically after 5 years in general practice? A longitudinal cohort analysis
Peter F M Verhaak et al. BMJ Open. 2019.
Abstract
Objectives: Antidepressant prescribing almost doubled in the Netherlands between 1996 and 2012, which could be accounted for by longer continuation after the first prescription. This might be problematic given a growing concern of large-scale antidepressant dependence. We aimed to assess the extent and determinants of chronic antidepressant prescribing among patient aged 18 years and older. We hypothesise a relatively large prevalence of chronic (>2 years) prescription.
Design: A longitudinal observational study based on routinely registered prescription data from general practice.
Setting: 189 general practices in the Netherlands.
Participants: 326 025 patients with valid prescription data for all 5 years of the study.
Outcome measures: Primary outcome measure: the number of patients (N) receiving at least four antidepressant prescriptions in 2011, as well as during each of the four subsequent years. Secondary outcome measure: the above, but specified for selective serotonin reuptake inhibitors and for tricyclic antidepressants.
Results: Antidepressants were prescribed to almost 7% of our 326 025 participants each year. They were prescribed for depression (38%), anxiety (17%), other psychological disorders (20%) and non-psychological indications (25%). Antidepressants were prescribed in all 5 years to the 42% of the population who had at least four prescriptions dispensed in 2011. Chronic prescribing was higher among women than men, for those aged 45-64 years than for those aged >65 years and for those treated for depression or anxiety than for non-psychological indications (eg, neuropathic pain). Chronic prescribing also varied markedly among general practices.
Conclusion: Chronic antidepressant use is common for depression and for anxiety and non-psychological diagnoses. Once antidepressants have been prescribed, general practitioners and other prescribers should be aware of the risks associated with long-term use and should provide annual monitoring of the continued need for therapy.
Keywords: anxiety disorders; primary care.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
- Antidepressant prescriptions and mental health nurses: an observational study in Dutch general practice from 2011 to 2015.
Magnée T, de Beurs DP, Schellevis FG, Verhaak PF. Magnée T, et al. Scand J Prim Health Care. 2018 Mar;36(1):47-55. doi: 10.1080/02813432.2018.1426145. Epub 2018 Jan 17. Scand J Prim Health Care. 2018. PMID: 29338537 Free PMC article. - Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system.
Wong J, Motulsky A, Abrahamowicz M, Eguale T, Buckeridge DL, Tamblyn R. Wong J, et al. BMJ. 2017 Feb 21;356:j603. doi: 10.1136/bmj.j603. BMJ. 2017. PMID: 28228380 Free PMC article. - Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK.
Murray ML, Thompson M, Santosh PJ, Wong IC. Murray ML, et al. Drug Saf. 2005;28(12):1151-7. doi: 10.2165/00002018-200528120-00009. Drug Saf. 2005. PMID: 16329717 - A systematic review and meta-analysis of prescribing practices of antidepressants in cancer patients.
Sanjida S, Janda M, Kissane D, Shaw J, Pearson SA, DiSipio T, Couper J. Sanjida S, et al. Psychooncology. 2016 Sep;25(9):1002-16. doi: 10.1002/pon.4048. Epub 2016 Jan 17. Psychooncology. 2016. PMID: 26775715 Review. - Why isn't bupropion the most frequently prescribed antidepressant?
Zimmerman M, Posternak MA, Attiullah N, Friedman M, Boland RJ, Baymiller S, Berlowitz SL, Rahman S, Uy KK, Singer S, Chelminski I. Zimmerman M, et al. J Clin Psychiatry. 2005 May;66(5):603-10. doi: 10.4088/jcp.v66n0510. J Clin Psychiatry. 2005. PMID: 15889947 Review.
Cited by
- The burden of disease of fatal and non-fatal burn injuries for the full spectrum of care in the Netherlands.
Spronk I, van Baar ME, Verheij RA, Panneman MJ, Dokter J, Polinder S, Haagsma JA. Spronk I, et al. Arch Public Health. 2023 Jan 9;81(1):3. doi: 10.1186/s13690-022-01020-z. Arch Public Health. 2023. PMID: 36617544 Free PMC article. - Familial risk of postpartum depression.
Rasmussen MH, Poulsen GJ, Wohlfahrt J, Videbech P, Melbye M. Rasmussen MH, et al. Acta Psychiatr Scand. 2022 Oct;146(4):340-349. doi: 10.1111/acps.13465. Epub 2022 Jul 25. Acta Psychiatr Scand. 2022. PMID: 35731191 Free PMC article. - Antidepressant prescribing patterns in Australia.
Malhi GS, Acar M, Kouhkamari MH, Chien TH, Juneja P, Siva S, Baune BT. Malhi GS, et al. BJPsych Open. 2022 Jun 30;8(4):e120. doi: 10.1192/bjo.2022.522. BJPsych Open. 2022. PMID: 35770420 Free PMC article. - How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding.
Hengartner MP. Hengartner MP. Ther Adv Psychopharmacol. 2020 May 8;10:2045125320921694. doi: 10.1177/2045125320921694. eCollection 2020. Ther Adv Psychopharmacol. 2020. PMID: 32435449 Free PMC article. Review. - Potential deprescribing indications for antidepressants between 2012 and 2019: repeated cross-sectional analysis in two Scottish health boards.
Brisnik V, Rottenkolber M, Vukas J, Schechner M, Lukaschek K, Jung-Sievers C, Gensichen J, Thiem U, Drey M, Krüger N, Mair A, Guthrie B, Fischer S, Dreischulte T; POKAL Study Group. Brisnik V, et al. BMC Med. 2024 Sep 11;22(1):378. doi: 10.1186/s12916-024-03584-9. BMC Med. 2024. PMID: 39256761 Free PMC article.
References
- Cipriani A, Furukawa TA, Salanti G, et al. . Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet 2018;391:1357–66. 10.1016/S0140-6736(17)32802-7 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical